Journal Article

Plasma Lipidomics Reveals Insights into Anti-Obesity Effect of Chrysanthemum morifolium Ramat Leaves and Its Constituent Luteolin in High-Fat Diet-Induced Dyslipidemic Mice

Choi, Myung-Sook, Kim, Won Cheol, Ryu, Ri, Wu, Zhexue, Seo, Jong-Su, Shon, Jong Cheol, Liu, Kwang-Hyeon

2020

Overview

The Chrysanthemum morifolium Ramat (CM) is widely used as a traditional medicine and herbal tea by the Asian population for its health benefits related to obesity. However, compared to the flowers of CM, detailed mechanisms underlying the beneficial effects of its leaves on obesity and dyslipidemia have not yet been elucidated. Therefore, to investigate the lipidomic biomarkers responsible for the pharmacological effects of CM leaf extract (CLE) in plasma of mice fed a high-fat diet (HFD), the plasma of mice fed a normal diet (ND), HFD, HFD plus CLE 1.5% diet, and HFD plus luteolin 0.003% diet (LU) for 16 weeks were analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS) combined with multivariate analysis. In our analysis, the ND, HFD, CLE, and LU groups were clearly differentiated by partial least-squares discriminant analysis (PLS-DA) score plots. The major metabolites contributing to this differentiation were cholesteryl esters (CEs), lysophosphatidylcholines (LPCs), phosphatidylcholines (PCs), ceramides (CERs), and sphingomyelins (SMs). The levels of plasma CEs, LPCs, PCs, SMs, and CERs were significantly increased in the HFD group compared to those in the ND group, and levels of these lipids recovered to normal after administration of CLE or LU. Furthermore, changes in hepatic mRNA expression levels involved in the Kennedy pathway and sphingolipid biosynthesis were also suppressed by treatment with CLE or LU. In conclusion, this study examined the beneficial effects of CLE and LU on obesity and dyslipidemia, which were demonstrated as reduced synthesis of lipotoxic intermediates. These results may provide valuable insights towards evaluating the therapeutic effects of CLE and LU and understanding obesity-related diseases.

• Publisher: MDPI AG,MDPI
• Subject: Animals / Anti-Obesity Agents - pharmacology / biomarkers / biosynthesis / ceramides / Ceramides - blood / Cholesterol Esters - blood / cholesteryl esters / Chromatography / Chromatography, Liquid / Chrysanthemum / Chrysanthemum morifolium / Diabetes / Diet, High-Fat - adverse effects / Dietary Supplements / discriminant analysis / Dyslipidemias - blood / Dyslipidemias - etiology / Dyslipidemias - therapy / Flavonoids / flowers / gene expression / herbal tea / high fat diet / hyperlipidemia / Hypertension / leaf extracts / least squares / leaves / Lipidomics / Lipids / liquid chromatography / Liver - metabolism / Liver diseases / luteolin / Luteolin - pharmacology / lysophosphatidylcholine / Lysophosphatidylcholines - blood / Male / Mass spectrometry / Metabolic disorders / Metabolic syndrome / Metabolites / Mice / Mice, Inbred C57BL / nutrients / Obesity / Obesity - blood / Obesity - etiology / Obesity - therapy / obesity-related diseases / Phosphatidylcholines - blood / Plant Extracts - pharmacology / Plant Leaves / Plasma / population / RNA, Messenger - metabolism / Scientific imaging / sphingomyelins / Sphingomyelins - blood / synthesis / Tandem Mass Spectrometry / therapeutics / Traditional medicine